BioCatalyst

TAK-788, Pemetrexed, Cisplatin, Carboplatin — catalyst calendar

1 verified catalyst event(s) referencing TAK-788, Pemetrexed, Cisplatin, Carboplatin, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-31
in 4mo
ESTIMATED
 READOUT
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
 TAK TAKEDA PHARMACEUTICAL CO LTD TAK-788, Pemetrexed, Cisplatin, Carbopla ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.